Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

ZeClinics

ZeClinics is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

View ZeClinics on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Agricultural Sciences Compliance and Quality Control Measures

  • Juvenile Growth Test Examine the adverse effects of recurrent and long-term toxin exposure on juvenile fish development.
  • Pesticide Product Testing Use laboratory assays to evaluate the efficacy, safety and selectivity of a pesticide under GLP standards.
  • Sediment-Water Toxicity Test Isolate the water of a sediment-based habitat to analyze the properties for toxicity evaluation.

Agricultural Sciences Research & Development

  • Agrochemical Analytical Method Development Engineer sensitive and selective methods that meet GLP validation requirements to assess different agrochemical properties.
  • Chronic Whole Effluent Toxicity(WET) Test Identify the effluent dilution that impairs growth, development or reproduction in aquatic organisms in 7 or more days of exposure.
  • General Agrochemical Compound Library Find potential compound candidates for agrochemical or agro-product research and development.

Antibodies

  • Antibody Detection Quantitate, localize and visualize proteins and other antigens.

Biomarkers

  • Anatomic Pathology Do macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
  • Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
  • Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
  • Cerebrospinal Fluid Analysis Use CSF to detect or monitor a variety of nervous system diseases or conditions.
  • Diagnostic Biomarkers Discovery Identify candidate biomarkers indicative of the presence of a disorder.
  • Hematoxylin & Eosin (H&E) Staining Visualize microscopic structures in cells or tissues.
Show all 11 in Biomarkers 5 more
  • Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
  • Immunohistochemistry Examine the toxic effects of pre-clinical compounds in small animal and patient histological samples.
  • Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
  • In Vivo Apoptosis Detection Visualize and quantify apoptosis in real time.
  • TUNEL Assay Detect in situ DNA fragmentation.
Show all 131 services 118 more

Cell Culture and Characterization

  • Cell and Tissue Histology Prepare and stain frozen, fixed and embedded (FFPE) tissue samples.
  • Cell Line Characterization Track source history and characterize cell lines to establish identity, purity and stability.
  • Cell Transfection Produce, package and optimize transfection of your siRNA or DNA construct.
  • Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.

Chemical and Compound Analysis

  • Adsorption/Desorption Studies Obtain data on groundwater risk assessment.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.

Chemical and Compound Testing

  • Nutritional Testing Analyze food safety, vendor specifications, foreign substance identification processes and nutritional labeling.
  • Product Testing Ensure product quality standards are met.

Clinical Trials

  • Clinical Research Services Determine the safety and effectiveness of medications and medical devices.
  • Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.

Developmental and Reproductive Toxicology (DART)

  • Early-Life Stage Toxicity Test Use survival and growth metrics of embryos or larvae to predict effects or find maximum acceptable value of a toxin.
  • Reproductive Toxicology Study adverse sexual function and fertility and examine teratogenicity of compounds.

Discovery Chemistry

  • Hit to Lead (H2L) Evaluate, perform limited optimization and identify small molecule hits from high throughput screens.
  • Leaching and Aged Leaching Assess the leaching potential of products with studies that follow the formation and movement of metabolites or show restricted leaching under simulated use conditions.
  • Lead Optimization Perform chemical structural changes to improve preclinical drug candidate.

Disease Models

  • Acute Liver Failure Models Measure therapeutic endpoints in animal models of acute liver failure.
  • Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
  • Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
  • Cognition Models Measure therapeutic endpoints in animal models of cognition.
  • Comparative Pharmacology Compare drug responses across species for improved reliability in translational studies.
  • Diabetic Retinopathy Models Assess therapeutic efficacy of drug candidates in diabetic retinopathy models of disease.
Show all 26 in Disease Models 20 more
  • Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.
  • Dry Eye Models Measure therapeutic endpoints such as tear induction, TBUT, Schirmer strips (tear volume) and cornea staining.
  • General Pain Models Measure therapeutic endpoints in animal models of general pain.
  • Huntington's Disease Models Measure therapeutic endpoints in animal models of Huntington's disease.
  • In Vivo Physiologic Monitoring Monitor and collect data from conscious, freely moving laboratory animals.
  • In Vivo Technologies Models Carry out EEGs, cognition assessment, microdialysis, electrophysiology, MRI, ultrasound and tomographic analysis.
  • Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
  • Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
  • Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
  • Liver Fibrosis Models Measure liver fibrosis using therapeutic endpoints such as collagen assessment, TUNEL staining and inflammatory markers.
  • Macular Degeneration Models Use a single animal species to create one or more models for eye disease.
  • Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
  • Ophthalmic Models Test drug candidates in glaucoma, macular degeneration, keratitis, uveitis and CMV retinitis models.
  • Otology Models Measure vertigo, tinnitus, otitis media and hearing loss in animal models.
  • Pain Endpoints Models Measure therapeutic endpoints in animal models of pain.
  • Pain Models Test therapeutic efficacy of drug candidate in pain model.
  • Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
  • Sclerosis ALS Models Measure therapeutic endpoints in animal models of sclerosis.
  • Ventricular Tachycardia Models Measure therapeutic endpoints in animal models of ventricular tachycardia.
  • Xenografts Evaluate drug candidate in tissue graft or organ transplant model.

DNA & RNA

  • CRISPR Using advanced CRISPR technology, add or delete base pairs at a specifically targeted DNA loci.
  • Genome Editing Use CRISPR, ZFN, TALEN or AAV gene targeting for targeted gene mutations and creation of transgenics.
  • Genotyping Examine a DNA sequence to identify specific genetic varients .
  • PCR Mutagenesis Use polymerase chain reaction to create mutations in a cloned gene.
  • Plasmid DNA Preparation and Extraction Prepare plasmid DNA starting from E. coli cell pellets, transformed colonies or DNA samples.

Drug Development

  • Safety Pharmacology Consulting Consulting services that help with the detection of potential undesirable pharmacodynamic effects of chemical entities on physiological functions.

Effectiveness

  • In Vitro Dose Determination Tests Determine the most appropriate effective drug dosage regimen(s) in vitro.
  • Laboratory Dose Confirmation Studies Conduct in vivo studies to confirm the effectiveness of a selected drug dose in the lab.
  • Laboratory Dose Determination Studies Compare the effectiveness of three non-zero therapeutic concentrations for various durations to a non-medicated control group, and a non-medicated uninfected control group.

Farm & Livestock Solutions

  • Soil Environmental Testing Measure environmental contaminants using soil sample analysis.
  • Soil Testing Use various tests to characterize a soil sample.

General in vivo Toxicology

  • General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
  • Short-Term Toxicity Tests Acquire preliminary data about the concentrations, exposure duration and effects of a toxin on organisms.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.

In Vitro Assays

  • Caspase Assay Detect early to mid stage apoptosis or differentiate apoptosis from necrosis.
  • High Content Screening Analyze whole cells or components of cells with simultaneous readout of several parameters.
  • HTS Assay Development Develop assays to use in high throughput screening.
  • In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.
  • Lipid Detection Use in vitro methods to identify lipid droplets and any associated proteins.
  • Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.

In Vitro Pharmacology

  • High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.
  • In Vitro Cardiovascular Models Measure stimulation and inhibition of lipolysis, adipogenesis and endothelial cell migration.
  • In Vitro Disease Models Screen pre-clinical candidates without the use of live animals.
  • In Vitro Hemolysis Assay Evaluate the toxicity of a drug, metabolite or excipient by hemolytic release of hemoglobin in the plasma.
  • In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
  • In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
Show all 9 in In Vitro Pharmacology 3 more
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.
  • Target Identification Identify the target(s) of a biologically active substance.
  • Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.

In Vitro Toxicology

  • Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
  • Cardiovascular Toxicology Measure the toxic effects of pre-clinical compounds.
  • Perfused Heart Examine cardiac contractile strength (inotropic effects), heart rate (chronotropic effects) and vascular effects.
  • Zebrafish Embryo Toxicity Use a single animal species to create one models of toxicity.

In Vivo ADME

  • Ocular Distribution Study - Other Species Conduct a study to determine the distribution of your compound in ocular tissues of other species.

Model Development

  • Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
  • Custom Model Development Develop a custom disease model.
  • Juvenile Toxicology Assess developmental and reproductive defects due to neurobehavioral, skeletal and muscle growth effects.
  • Standard Models Create new animal disease models or modify existing models to study specific diseases, side-effects or symptoms.
  • Transgenic Models Create animal models engineered for use in a specific therapeutic area.
  • Zebrafish Animal Model Model human disease and development in zebrafish.

Oncology Models

  • Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
  • Oncology Xenografts Xenografts derived from oncological samples.
  • Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.

Other Specialty Toxicology

  • Biosafety Testing Consulting Expert advice to conduct safe and responsible biological procedures and practices.
  • Ocular Phototoxicity Study - Other Species Conduct a study to determine the extent to which your compound is capable of producing phototoxic side effects in ocular tissues of other species.
  • Raw Materials Testing Verify that raw materials are sterile and not contaminated by mycoplasma, virus or other microorganisms.
  • Semi-Static Acute Toxicity Test Measure toxicity endpoints in aquatic organisms exposed to renewed test solutions at defined intervals of an experiment.
  • Static Acute Toxicity Test Measure toxicity endpoints in aquatic organisms exposed to a non-renewed test solution for the entire experiment.
  • Tumorigenicity Testing Test tumor-forming properties of cell products.

REACH Services

  • OECD 421: Reproduction/Developmental Toxicity Screening Test The test substance is administered in graduated doses to several groups of males and females.
  • OECD 426: Developmental Neurotoxicity Study A developmental neurotoxicity study will provide information on the effects of repeated exposure to a substance during in utero and early postnatal development.
  • OECD 452: Chronic Toxicity Studies Evaluate the direct and indirect impact of prolonged and repeated toxin exposure to test organisms.

Regulatory Consulting

  • Environmental Fate and Ecotoxicology Data Review Identify relevant endpoints for fate and behavior (metabolism and excretion, degradation and soil adsorption) and toxicity (soil organisms, aquatic organisms, and dung fauna) of animal health products.
  • Environmental Risk Assessment Conduct EU and US Environmental Assessment (ERA/EA) phases one and two according to VICH guidelines.
  • Toxicology Data Review Identify relevant toxicological endpoints for “No Observed (Adverse) Effect Level” (NO(A)EL) or “Lowest Observed (Adverse) Effect Level” (LO(A)EL).

Safety Pharmacology

  • CNS Behavioral Measure safety toxicology effects of CNS and behavioral drugs.
  • Developmental Neurotoxicty Study - Other Species A developmental neurotoxicity study will provide information on the effects of repeated exposure to a substance during in utero and early postnatal development.
  • Endocrine Disruptor Screening Use biochemical, cell based or in vivo assays to identify and quantify endocrine-modulating agents.
  • Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
  • Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.

Specialty Dosing Routes

  • Intravitreal Toxicity and/or Toxicokinetic Study - Other Species Conduct an intravitreal ocular toxicity study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Lethal Dose (LD), 50% Toxicity Test Measure acute toxicity by identifying the amount of pure toxin required to kill half of the experimental subjects.

Target Animal and Human Food Safety

  • Target Animal Safety (TAS) Studies Evaluate potential harmful effects associated with the use of a new animal drug in a controlled setting.
  • Tolerance Studies Conduct tolerance studies on target animals of veterinary products.
  • Toxicity Test for Veterinary Drugs Use the drug at 10X the recommended dose for 3X the recommended duration to evaluate its safety.
  • Toxicokinetic Analysis Determine the drug concentration at which off-target or toxic effects occur.

Testing Services

  • Skin Elasticity Testing Measure the skin's ability to resist pressure (firmness) and its ability to return to its original position pre- and post-treatment.
  • Skin Lightening Product Test Measure qualitative and quantitative changes in skin pigmentation under the influence of the test sample.

Other services

  • proxy-CRISPR Gain access to previously unreachable areas of the genome via proxy-CRISPR, a proximal CRISPR targeting method that restores FnCas9 nuclease activity.
  • Transcriptome In Vivo Analysis (TIVA) Use TIVA for photo-activated capture of mRNA from a single cell or sub-cellular region.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • Spain Sant Feliu de Llobregat 1 site

Source: Scientist.com supplier network (site locations)

Get the ZeClinics report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with ZeClinics on Scientist.com

For prices, more details, or to contact ZeClinics, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.